| Endpoints | Group A 0–2 Days (N=120) | Group B 2–4 Days (N=157) | Group C >4 Days (N=45) | Log Rank P-Value |
|---|---|---|---|---|
| Pre-Transplant FEV1/FVC<70% | 11.7%(14/120) | 19.1%(33/157) | 17.8%(8/45) | P=0.052 Group A vs. B |
| ECMO DuringVentilation | 2.5%(3/120) | 1.9%(3/157) | 28.9%(13/45) | P<0.05 Group A vs. C Group B vs. C |
| 1-Year Survival | 92.0% | 93.0% | 66.6%*** | <0.001 |
| 1-Year Freedomfrom Any Treated Rejection | 82.0% | 86.9% | 77.9% | 0.313 |
*p<0.05 compared to Group A (0–2 Days).
**p<0.05 compared to Group B (2–4 Days).